Plasmapheresis, Anti-ACE2 and Anti-FcγRII Monoclonal Antibodies: A Possible Treatment for Severe Cases of COVID-19

Amin Sedokani,1 Sadegh Feizollahzadeh2 1Cardiology Department, Medical Faculty, Urmia University of Medical Sciences, Urmia, Iran; 2Medical Immunology, Laboratory Sciences, School of Allied Medical Sciences, Urmia University of Medical Sciences, Urmia, IranCorrespondence: Amin SedokaniCardiology Dep...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Sedokani A (Auteur), Feizollahzadeh S (Auteur)
Format: Livre
Publié: Dove Medical Press, 2020-07-01T00:00:00Z.
Sujets:
Accès en ligne:Connect to this object online.
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

Connect to this object online.

3rd Floor Main Library

Informations d'exemplaires de 3rd Floor Main Library
Cote: A1234.567
Exemplaire 1 Disponible